Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events.
Τίτλος | Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events. |
Publication Type | Journal Article |
Year of Publication | 2015 |
Authors | Aronis, K. N., Moreno M., Polyzos S. A., Moreno-Navarrete J. M., Ricart W., Delgado E., de la Hera J., Sahin-Efe A., Chamberland J. P., Berman R., Spiro A., Vokonas P., Fernández-Real J. M., & Mantzoros C. S. |
Journal | Int J Obes (Lond) |
Volume | 39 |
Issue | 1 |
Pagination | 156-61 |
Date Published | 2015 Jan |
ISSN | 1476-5497 |
Λέξεις κλειδιά | Acute Coronary Syndrome, Adult, Aged, Case-Control Studies, Cohort Studies, Coronary Artery Disease, Female, Fibronectins, Humans, Insulin Resistance, Male, Middle Aged, Muscle, Skeletal, PPAR gamma, Predictive Value of Tests, Prospective Studies, Treatment Outcome |
Abstract | INTRODUCTION: Irisin is a newly discovered myokine, associated with 'browning' of the white adipose tissue, obesity, insulin resistance and metabolic syndrome. The purpose of this study is to evaluate circulating irisin as a predictor of acute coronary syndromes (ACSs) and major adverse cardiovascular events (MACE). |
DOI | 10.1038/ijo.2014.101 |
Alternate Journal | Int J Obes (Lond) |
PubMed ID | 24916788 |